• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Clinical trials

Clinical trials

Page 4 of 4

Novavax Stock Plunges After Respiratory Disease Vaccine Fails in Trial
Health

Novavax Stock Plunges After Respiratory Disease Vaccine Fails in Trial

By Tech Reporter
September 16, 2016
Trading On The Floor Of The NYSE As U.S. Stocks Rise Amid Stronger Job Gains Boost Optimism On Economy
Health

Bristol-Myers Squibb Shares Tanked Today and It’s Great News for Merck

By Staff Writer
August 5, 2016
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
Health

Why Shares of Next-Gen Cancer Biotech Juno Rallied Today

By Industry Analyst
July 14, 2016
FRANCE-POLITICS-INDUSTRY
Finance

Why This Pharma Giant Lost $8 Billion in Market Cap This Week

By Trading Desk
June 16, 2016
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
Health

Cancer Drugs Are The Least Likely to Receive FDA Approval

By Contributing Writer
May 26, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Health

Struggling Novartis Heart Drug Boosted by New Medical Guidelines

By Staff Writer
May 21, 2016
IBM AND PFIZER COLLABORATING TO CREAT MONITORING SYSTEM TO SUPPORT PATIENTS WITH PARKINSON'S
Health

Pfizer and IBM Launch Innovative Research Project to Transform Parkinson’s Disease Care

By Investment Desk
April 7, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Health

Novartis Takes Entresto Case to U.S. Cardiologist Meeting

By Blockchain Reporter
April 2, 2016
The Newly Refurbished Charles Dickens Museum Prepares To Open
Health

Female Viagra Might Not Be All It’s Cracked Up To Be

By Industry Analyst
March 1, 2016
Key Speakers At The 2015 Milken Conference
Health

Controversial Billionaire Inspired by Biden to Start Cancer Research Group

By Industry Analyst
January 14, 2016
467180057
Commentary

How to take clinical research to the next level

By Contributing Writer
October 26, 2015
SAN FRANCISCO, CA - MARCH 9: Apple CEO Tim Cook stands in front of a ResearchKit logo during an Apple special event at the Yerba Buena Center for the Arts on March 9, 2015 in San Francisco, California. Apple Inc. announced the new MacBook as well as more details on the much anticipated Apple Watch, the tech giant's entry into the rapidly growing wearable technology segment as well (Photo by Stephen Lam/Getty Images)
Health

New Apple ResearchKit trials focus on epilepsy, autism and skin cancer

By Blockchain Reporter
October 15, 2015

Most Popular

  • AI
    Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
    By Blockchain Reporter
  • Economy
    One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
    By Trading Desk
  • Economy
    Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
    By Market Analyst
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.